Cargando…

Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores

This study examines the possibility of directly producing and utilizing useful substances in the intestines of animals using anaerobic bacteria that can grow in the intestines of animals. A facultative anaerobe producing a large amount of α-glucosidase inhibitor was isolated from hay and identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee-Woong, Choi, Soo-Young, Lee, Deug-Chan, Rhee, Hae-Ik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303644/
https://www.ncbi.nlm.nih.gov/pubmed/37374964
http://dx.doi.org/10.3390/microorganisms11061462
_version_ 1785065325228720128
author Kim, Hee-Woong
Choi, Soo-Young
Lee, Deug-Chan
Rhee, Hae-Ik
author_facet Kim, Hee-Woong
Choi, Soo-Young
Lee, Deug-Chan
Rhee, Hae-Ik
author_sort Kim, Hee-Woong
collection PubMed
description This study examines the possibility of directly producing and utilizing useful substances in the intestines of animals using anaerobic bacteria that can grow in the intestines of animals. A facultative anaerobe producing a large amount of α-glucosidase inhibitor was isolated from hay and identified and named Bacillus coagulans CC. The main compound of α-glucosidase inhibitor produced by Bacillus coagulans CC was identified as 1-deoxynojirimycin. α-glucosidase inhibitor activity was confirmed in the intestinal contents and feces of mice orally administered with spores of this strain, and it was confirmed that this strain could efficiently reach the intestines, proliferate, and produce α-glucosidase inhibitors. As a result of administering Bacillus coagulans CC to mice at 10(9) cells per 1 kg body weight of spores for 8 weeks, the high-carbohydrate diet and the high-fat diet showed a 5% lower weight gain compared to the non-administrated group. At this point, in the spore-administered group, a decrease was observed in both the visceral and subcutaneous fat layers of the abdomen and thorax in both high-carbohydrate and high-fat diet groups compared to the non-administered group on computed tomography. The results of this study show that α-glucosidase inhibitors produced in the intestine by specific strains can work efficiently.
format Online
Article
Text
id pubmed-10303644
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103036442023-06-29 Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores Kim, Hee-Woong Choi, Soo-Young Lee, Deug-Chan Rhee, Hae-Ik Microorganisms Article This study examines the possibility of directly producing and utilizing useful substances in the intestines of animals using anaerobic bacteria that can grow in the intestines of animals. A facultative anaerobe producing a large amount of α-glucosidase inhibitor was isolated from hay and identified and named Bacillus coagulans CC. The main compound of α-glucosidase inhibitor produced by Bacillus coagulans CC was identified as 1-deoxynojirimycin. α-glucosidase inhibitor activity was confirmed in the intestinal contents and feces of mice orally administered with spores of this strain, and it was confirmed that this strain could efficiently reach the intestines, proliferate, and produce α-glucosidase inhibitors. As a result of administering Bacillus coagulans CC to mice at 10(9) cells per 1 kg body weight of spores for 8 weeks, the high-carbohydrate diet and the high-fat diet showed a 5% lower weight gain compared to the non-administrated group. At this point, in the spore-administered group, a decrease was observed in both the visceral and subcutaneous fat layers of the abdomen and thorax in both high-carbohydrate and high-fat diet groups compared to the non-administered group on computed tomography. The results of this study show that α-glucosidase inhibitors produced in the intestine by specific strains can work efficiently. MDPI 2023-05-31 /pmc/articles/PMC10303644/ /pubmed/37374964 http://dx.doi.org/10.3390/microorganisms11061462 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Hee-Woong
Choi, Soo-Young
Lee, Deug-Chan
Rhee, Hae-Ik
Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores
title Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores
title_full Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores
title_fullStr Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores
title_full_unstemmed Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores
title_short Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores
title_sort intestinal production of alpha-glucosidase inhibitor by bacillus coagulans spores
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303644/
https://www.ncbi.nlm.nih.gov/pubmed/37374964
http://dx.doi.org/10.3390/microorganisms11061462
work_keys_str_mv AT kimheewoong intestinalproductionofalphaglucosidaseinhibitorbybacilluscoagulansspores
AT choisooyoung intestinalproductionofalphaglucosidaseinhibitorbybacilluscoagulansspores
AT leedeugchan intestinalproductionofalphaglucosidaseinhibitorbybacilluscoagulansspores
AT rheehaeik intestinalproductionofalphaglucosidaseinhibitorbybacilluscoagulansspores